Skip to main content
Intended for healthcare professionals
Restricted access
Review article
First published online November 18, 2024

Whole Slide Imaging, Artificial Intelligence, and Machine Learning in Pediatric and Perinatal Pathology: Current Status and Future Directions

Abstract

The integration of artificial intelligence (AI) into healthcare is becoming increasingly mainstream. Leveraging digital technologies, such as AI and deep learning, impacts researchers, clinicians, and industry due to promising performance and clinical potential. Digital pathology is now a proven technology, enabling generation of high-resolution digital images from glass slides (whole slide images; WSI). WSIs facilitates AI-based image analysis to aid pathologists in diagnostic tasks, improve workflow efficiency, and address workforce shortages. Example applications include tumor segmentation, disease classification, detection, quantitation and grading, rare object identification, and outcome prediction. While advancements have occurred, integration of WSI-AI into clinical laboratories faces challenges, including concerns regarding evidence quality, regulatory adaptations, clinical evaluation, and safety considerations. In pediatric and developmental histopathology, adoption of AI could improve diagnostic efficiency, automate routine tasks, and address specific diagnostic challenges unique to the specialty, such as standardizing placental pathology and developmental autopsy findings, as well as mitigating staffing shortages in the subspeciality. Additionally, AI-based tools have potential to mitigate medicolegal implications by enhancing reproducibility and objectivity in diagnostic evaluations. An overview of recent developments and challenges in applying AI to pediatric and developmental pathology, focusing on machine learning methods applied to WSIs of pediatric pathology specimens is presented.

Get full access to this article

View all access and purchase options for this article.

References

1. Elemento O, Leslie C, Lundin J, Tourassi G. Artificial intelligence in cancer research, diagnosis and therapy. Nat Rev Cancer. 2021;21:747-752.
2. Beam AL, Kohane IS. Big data and machine learning in health care. JAMA. 2018;319:1317-1318.
3. Duggal R, Brindle I, Bagenal J. Digital healthcare: regulating the revolution. BMJ. 2018;360:k6.
4. Wang F, Casalino LP, Khullar D. Deep learning in medicine-promise, progress, and challenges. JAMA Intern Med. 2019;179:293-294.
5. Topol E. Deep Medicine. 2024. Accessed April 2, 2024. https://drerictopol.com/portfolio/deep-medicine/
6. Topol EJ. High-performance medicine: the convergence of human and artificial intelligence. Nat Med. 2019;25:44-56.
7. Paul D, Sanap G, Shenoy S, Kalyane D, Kalia K, Tekade RK. Artificial intelligence in drug discovery and development. Drug Discov Today. 2021;26:80-93.
8. Juhn Y, Liu H. Artificial intelligence approaches using natural language processing to advance EHR-based clinical research. J Allergy Clin Immunol. 2020;145:463-469.
9. Panesar S, Cagle Y, Chander D, Morey J, Fernandez-Miranda J, Kliot M. Artificial intelligence and the future of surgical robotics. Ann Surg. 2019;270:223-226.
10. McKinney SM, Sieniek M, Godbole V, et al. International evaluation of an AI system for breast cancer screening. Nature. 2020;577:89-94.
11. Nahavandi D, Alizadehsani R, Khosravi A, Acharya UR. Application of artificial intelligence in wearable devices: opportunities and challenges. Comput Methods Programs Biomed. 2022;213:106541.
12. Aggarwal R, Sounderajah V, Martin G, et al. Diagnostic accuracy of deep learning in medical imaging: a systematic review and meta-analysis. NPJ Digit Med. 2021;4:65.
13. Gulshan V, Peng L, Coram M, et al. Development and validation of a deep learning algorithm for detection of diabetic retinopathy in retinal fundus photographs. JAMA. 2016;316:2402-2410.
14. Rudnicka AR, Welikala R, Barman S, et al. Artificial intelligence-enabled retinal vasculometry for prediction of circulatory mortality, myocardial infarction and stroke. Br J Ophthalmol. 2022;106:1722-1729.
15. Cheung CY, Ran AR, Wang S, et al. A deep learning model for detection of Alzheimer’s disease based on retinal photographs: a retrospective, multicentre case-control study. Lancet Digit Health. 2022;4:e806-e815.
16. Dhungel N, Carneiro G, Bradley AP. A deep learning approach for the analysis of masses in mammograms with minimal user intervention. Med Image Anal. 2017;37:114-128.
17. UrRehman Z, Qiang Y, Wang L, et al. Effective lung nodule detection using deep CNN with dual attention mechanisms. Sci Rep. 2024;14(1):3934. Accessed April 2, 2024. https://pubmed.ncbi.nlm.nih.gov/38365831/
18. Esteva A, Kuprel B, Novoa RA, et al. Dermatologist-level classification of skin cancer with deep neural networks. Nature. 2017;542:115-118.
19. Stead WW. Clinical implications and challenges of artificial intelligence and deep learning. JAMA. 2018;320:1107-1108.
20. Srinidhi CL, Ciga O, Martel AL. Deep neural network models for computational histopathology: a survey. Med Image Anal. 2021;67:101813.
21. Griffin J, Treanor D. Digital pathology in clinical use: where are we now and what is holding us back? Histopathology. 2017;70:134-145.
22. Niazi MKK, Parwani AV, Gurcan MN. Digital pathology and artificial intelligence. Lancet Oncol. 2019;20:e253-e261.
23. Martin J. Meeting Pathology Demand: Histopathology Workforce Census. Royal College of Pathologists; 2018.
24. Wilson ML, Fleming KA, Kuti MA, Looi LM, Lago N, Ru K. Access to pathology and laboratory medicine services: a crucial gap. Lancet. 2018;391:1927-1938.
25. McGenity C, Wright A, Treanor D. AIM in surgical pathology. In: Lidströmer N, Ashrafian H, eds. Artificial Intelligence in Medicine. Springer; 2021:1-18.
26. Ibrahim A, Gamble P, Jaroensri R, et al. Artificial intelligence in digital breast pathology: techniques and applications. Breast. 2020;49:267-273.
27. Goldenberg SL, Nir G, Salcudean SE. A new era: artificial intelligence and machine learning in prostate cancer. Nat Rev Urol. 2019;16:391-403.
28. Ehteshami Bejnordi B, Veta M, Johannes van Diest P, et al. Diagnostic assessment of deep learning algorithms for detection of lymph node metastases in women with breast cancer. JAMA. 2017;318:2199-2210.
29. Tolkach Y, Ovtcharov V, Pryalukhin A, et al. An international multi-institutional validation study of the algorithm for prostate cancer detection and Gleason grading. NPJ Precis Oncol. 2023;7:77.
30. Lu MY, Chen TY, Williamson DFK, et al. AI-based pathology predicts origins for cancers of unknown primary. Nature. 2021;594:106-110.
31. Kers J, Bülow RD, Klinkhammer BM, et al. Deep learning-based classification of kidney transplant pathology: a retrospective, multicentre, proof-of-concept study. Lancet Digit Health. 2022;4:e18-e26.
32. Korbar B, Olofson AM, Miraflor AP, et al. Deep learning for classification of colorectal polyps on whole-slide images. J Pathol Inform. 2017;8:30.
33. Heinemann F, Birk G, Stierstorfer B. Deep learning enables pathologist-like scoring of NASH models. Sci Rep. 2019;9:18454.
34. Tran KA, Kondrashova O, Bradley A, Williams ED, Pearson JV, Waddell N. Deep learning in cancer diagnosis, prognosis and treatment selection. Genome Med. 2021;13:152.
35. Viscosi C, Fidelbo P, Benedetto A, Varvarà M, Ferrante M. Selection of diagnosis with oncologic relevance information from histopathology free text reports: a machine learning approach. Int J Med Inform. 2022;160:104714.
36. Rocco B, Sighinolfi MC, Sandri M, et al. Digital biopsy with fluorescence confocal microscope for effective real-time diagnosis of prostate cancer: a prospective, comparative study. Eur Urol Oncol. 2021;4:784-791.
37. Reichardt M, Moller Jensen P, Andersen Dahl V, et al. 3D virtual histopathology of cardiac tissue from Covid-19 patients based on phase-contrast X-ray tomography. Elife. 2021;10:e71359.
38. Baxi V, Edwards R, Montalto M, Saha S. Digital pathology and artificial intelligence in translational medicine and clinical practice. Mod Pathol. 2022;35:23-32.
39. Plana D, Shung DL, Grimshaw AA, Saraf A, Sung JJY, Kann BH. Randomized clinical trials of machine learning interventions in health care: a systematic review. JAMA Netw Open. 2022;5:e2233946.
40. Yusuf M, Atal I, Li J, et al. Reporting quality of studies using machine learning models for medical diagnosis: a systematic review. BMJ Open. 2020;10:e034568.
41. Iqbal JD, Biller-Andorno N. The regulatory gap in digital health and alternative pathways to bridge it. Health Policy Technol. 2022;11:100663.
42. Liang W, Tadesse GA, Ho D, et al. Advances, challenges and opportunities in creating data for trustworthy AI. Nat Mach Intell. 2022;4:669-677.
43. Pantanowitz L, Sharma A, Carter AB, Kurc T, Sussman A, Saltz J. Twenty years of digital pathology: an overview of the road travelled, what is on the Horizon, and the emergence of vendor-neutral archives. J Pathol Inform. 2018;9:40.
44. The Royal College of Pathologists. The pathology workforce. 2024. Accessed July 25, 2024. https://www.rcpath.org/discover-pathology/public-affairs/the-pathology-workforce.html
45. Pantanowitz L, Hartman D, Qi Y, et al. Accuracy and efficiency of an artificial intelligence tool when counting breast mitoses. Diagn Pathol. 2020;15:80.
46. Dellon ES, Liacouras CA, Molina-Infante J, et al. Updated international consensus diagnostic criteria for eosinophilic esophagitis: proceedings of the AGREE conference. Gastroenterology. 2018;155:1022-1033.e10.
47. Larey A, Aknin E, Daniel N, et al. Harnessing artificial intelligence to infer novel spatial biomarkers for the diagnosis of eosinophilic esophagitis. Front Med. 2022;9:950728.
48. Khong TY, Mooney EE, Ariel I, et al. Sampling and definitions of placental lesions: amsterdam placental workshop group consensus statement. Arch Pathol Lab Med. 2016;140:698-713.
49. Stevens DU, de Nobrega Teixeira JA, Spaanderman MEA, Bulten J, van Vugt JMG, Al-Nasiry S. Understanding decidual vasculopathy and the link to preeclampsia: a review. Placenta. 2020;97:95-100.
50. Clymer D, Kostadinov S, Catov J, et al. Decidual vasculopathy identification in whole slide images using multiresolution hierarchical convolutional neural networks. Am J Pathol. 2020;190:2111-2122.
51. Hwang S, Kapur RP. Advances and pitfalls in the diagnosis of hirschsprung disease. Surg Pathol Clin. 2020;13:567-579.
52. Soares de, Oliveira MA, Galganski L, Stokes S, et al. Diagnosing Hirschsprung disease by detecting intestinal ganglion cells using label-free hyperspectral microscopy. Sci Rep. 2021;11:1398.
53. Greenberg A, Aizic A, Zubkov A, Borsekofsky S, Hagege RR, Hershkovitz D. Automatic ganglion cell detection for improving the efficiency and accuracy of hirschprung disease diagnosis. Sci Rep. 2021;11:3306.
54. Greenberg A, Samueli B, Fahoum I, et al. Short training significantly improves Ganglion cell detection using an algorithm-assisted approach. Arch Pathol Lab Med. 2023;147:215-221.
55. Schilling F, Geppert CE, Strehl J, et al. Digital pathology imaging and computer-aided diagnostics as a novel tool for standardization of evaluation of aganglionic megacolon (Hirschsprung disease) histopathology. Cell Tissue Res. 2019;375:371-381.
56. Kidron D, Vainer I, Fisher Y, Sharony R. Automated image analysis of placental villi and syncytial knots in histological sections. Placenta. 2017;53:113-118.
57. Huang S-C, Chen C-C, Lan J, et al. Deep neural network trained on gigapixel images improves lymph node metastasis detection in clinical settings. Nat Commun. 2022;13:3347.
58. Ginley B, Jen K-Y, Han SS, et al. Automated computational detection of interstitial fibrosis, tubular atrophy, and glomerulosclerosis. J Am Soc Nephrol. 2021;32:837-850.
59. Gawrieh S, Sethunath D, Cummings OW, et al. Automated quantification and architectural pattern detection of hepatic fibrosis in NAFLD. Ann Diagn Pathol. 2020;47:151518.
60. Silva MA, Triltsch N, Leis S, et al. Biomarker recommendation for PD-1/PD-L1 immunotherapy development in pediatric cancer based on digital image analysis of PD-L1 and immune cells. J Pathol Clin Res. 2020;6:124-137.
61. Irwin MS, Naranjo A, Zhang FF, et al. Revised neuroblastoma risk classification system: a report from the children’s oncology group. J Clin Oncol. 2021;39:3229-3241.
62. Bhardwaj N, Rohilla M, Trehan A, Bansal D, Kakkar N, Srinivasan R. Mitosis-Karyorrhexis Index evaluation by digital image visual analysis for application of International Neuroblastoma Pathology Classification in FNA biopsy. Cancer Cytopathol. 2022;130:128-135.
63. Sertel O, Kong J, Shimada H, Catalyurek UV, Saltz JH, Gurcan MN. Computer-aided prognosis of neuroblastoma on whole-slide images: classification of stromal development. Pattern Recognit. 2009;42:1093-1103.
64. Milewski D, Jung H, Brown GT, et al. Predicting molecular subtype and survival of rhabdomyosarcoma patients using deep learning of H&E images: a report from the children’s oncology group. Clin Cancer Res. 2023;29:364-378.
65. van der Kamp A, Waterlander TJ, de Bel T, et al. Artificial intelligence in pediatric pathology: the extinction of a medical profession or the key to a bright future? Pediatr Dev Pathol. 2022;25(4):380-387.
66. Arnold MA, Chenever E, Baker PB, et al. The College of American Pathologists guidelines for whole slide imaging validation are feasible for pediatric pathology: a pediatric pathology practice experience. Pediatr Dev Pathol. 2015;18:109-116.
67. Al-Janabi S, Huisman A, Nikkels PGJ, Kate FJWT, Van Diest PJ. Whole slide images for primary diagnostics of paediatric pathology specimens: a feasibility study. J Clin Pathol. 2013;66:218-223.
68. Evans AJ, Depeiza N, Allen S-G, Fraser K, Shirley S, Chetty R. Use of whole slide imaging (WSI) for distance teaching. J Clin Pathol. 2021;74:425-428.
69. Dhaliwal J, Erdman L, Drysdale E, et al. Accurate classification of pediatric colonic inflammatory bowel disease subtype using a random forest machine learning classifier. J Pediatr Gastroenterol Nutr. 2021;72:262-269.
70. Syed S, Al-Boni M, Khan MN, et al. Assessment of machine learning detection of environmental enteropathy and celiac disease in children. JAMA Netw Open. 2019;2:e195822.
71. Zeng L, Li SH, Xu SY, et al. Clinical significance of a CD3/CD8-based immunoscore in neuroblastoma patients using digital pathology. Front Immunol. 2022;13:878457.
72. Bussola N, Papa B, Melaiu O, Castellano A, Fruci D, Jurman G. Quantification of the immune content in neuroblastoma: deep learning and topological data analysis in digital pathology. Int J Mol Sci. 2021;22:8804.
73. Gheisari S, Catchpoole DR, Charlton A, Melegh Z, Gradhand E, Kennedy PJ. Computer aided classification of neuroblastoma histological images using scale invariant feature transform with feature encoding. Diagnostics. 2018;8:56.
74. Vujanić GM, Sandstedt B, Kelsey A, Sebire NJ. Central pathology review in multicenter trials and studies. Cancer. 2009;115:1977-1983.
75. Khong TY, Staples A, Bendon RW, et al. Observer reliability in assessing placental maturity by histology. J Clin Pathol. 1995;48:420-423.